Retrospective Study of Patient Surveys

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-22

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To collect data from Allergan Patient Surveys (patient surveys) and Allergan Patient Information Form (patient information form) to describe:

1. Patient demographics
2. Treatment patterns
3. Patient feedback and overall experience with MMS treatment

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Submental Study (Sequential Treatment Approach)

NCT03510598

Body Fat Disorder

COMPLETED PHASE4

Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults

NCT02354807

Brown Fat

UNKNOWN PHASE2

Efficacy and Safety of ALT-801 in the Treatment of Obesity

NCT05295875

Obesity/Overweight

COMPLETED PHASE2

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

NCT00482196

Obesity

COMPLETED PHASE2

Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

NCT05351164

Lipomatosis, Multiple Symmetrical

ACTIVE_NOT_RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Fat Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Questionnaire Review

Group Type OTHER

Questionnaire review

Intervention Type OTHER

Review data from questionnaires received about MMS experience.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire review

Review data from questionnaires received about MMS experience.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has received MMS treatment in the abdomen and/or buttocks (with CoolTone prototype)
* Subject has completed the Allergan patient survey and information form on MMS experience between July 1, 2019 and December 1, 2019.

Minimum Eligible Age

22 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes